Montelukast, a drug used for asthma or hay fever, may help to treat children suffering from Obstructive Sleep Apnea (OSA), according to a study. The study, by Ben-Gurion University of the Negev (BGU) researchers, showed significant improvement in respiratory disturbance and adenoid size.
A considerable percentage of children who suffer from OSA and undergo tonsillectomies and polypectomies occasionally suffer from post-operative infection, bleeding and dehydration. Some children experience a reoccurrence of the condition.
According to Dr. Aviv Goldbart, a researcher in BGU's Faculty of Health Sciences, "Our goal is to find non-invasive treatments for OSA. We are seeking a nonsurgical treatment that will be used instead of tonsillectomies and polypectomies in children, and as a replacement for continuous positive airway pressure (CPAP) machines for adults."